---

Wendel Doubleday

Director, Process Research & Development, Seattle Genetics

Wendel leads Seattle Genetics’ process chemistry department, which focuses on the development of novel chemical processes for highly potent drug-linkers. He is currently responsible for defining how processes for cytotoxic agents can be safely and efficiently developed within a biotech environment, and transferred to external manufacturing.

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016